Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Anand outlines current state of play in hedge fund merger and acquisition activity

Monday, July 01, 2013

Beverly Chandler, Opalesque London:

Speaking at the London Emerging Manager Forum, Ravi Anand, head of corporate finance at Dexion Capital said that the hedge fund industry has been evolving and changing a great deal over recent years, running in parallel with private equity.

Anand said that the first step in analysing merger and acquisition activity in the hedge fund sector was to estimate how big hedge funds are relative to asset management in general. With the hedge fund industry estimated to have some $2.3tln under management, it is a tiny concentrated part of asset management in general, Anand said. And the concentration means that 5% of funds represent more than 65% of the industry and 9% of funds of funds control more than 33% of the assets.

Reasons why there has been merger and acquisition activity includes funds that are sub-scale and fund management groups on the prowl for alpha and hedge fund skills. Since 2010, Anand told his audience, there have been 80 m&a transactions in hedge funds, against 400 in asset management firms generally. Key drivers, Anand said, are distribution, distress and financial.

Future drivers for m&a activity in hedge funds are regulation and operational scale. "AIFMD is going to affect people’s ability to function going forward" Anand said. Another trend that has appeared in the US is for private equity groups to......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its